Hospira (HSP -9.1%) shares plunge after RBC Capital says the generic injectable drug maker may...
Hospira (HSP -9.1%) shares plunge after RBC Capital says the generic injectable drug maker may face “widespread” production breakdowns that could take two to three years to correct. Hospira has been working to correct flaws that led to recalls of two drugs in 2009 and 2010, but RBC believes the company’s manufacturing issues are "far greater than investors realize."
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at MarketWatch.com (Feb 12, 2015)
at Benzinga.com (Feb 12, 2015)
at MarketWatch.com (Feb 10, 2015)
at Investor's Business Daily (Feb 5, 2015)
at CNBC.com (Feb 5, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs